β-Catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial–myofibroblast transition

Por Charbonney, Emmanuel, Speight, Pam, Masszi, András, Nakano, Hiroyasu, Kapus, András
Publicado em 2011

Analyses of Donor-Derived Keratinocytes in Hairy and Nonhairy Skin Biopsies of Female Patients Following Allogeneic Male Bone Marrow Transplantation

Por Nemeth, Krisztian, Key, Sharon, Bottlik, Gyula, Masszi, Tamas, Mezey, Eva, Karpati, Sarolta
Publicado em 2012

Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3

Por Masszi, András, Speight, Pam, Charbonney, Emmanuel, Lodyga, Monika, Nakano, Hiroyasu, Szászi, Katalin, Kapus, András
Publicado em 2010

Integrity of Cell-Cell Contacts Is a Critical Regulator of TGF-β1-Induced Epithelial-to-Myofibroblast Transition : Role for β-Catenin

Por Masszi, András, Fan, Lingzhi, Rosivall, László, McCulloch, Christopher A., Rotstein, Ori D., Mucsi, István, Kapus, András
Publicado em 2004

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

Por Bérczi, Viktor, Rudas, Gábor, Kozák, Lajos Rudolf, Györke, Tamás, Mikala, Gábor, Masszi, Tamás, Kalina, Ildikó, Kaposi, Pál Novák
Publicado em 2014

Accelerated clearance alone explains ultralarge multimers in VWD Vicenza

Por Gézsi, András, Budde, Ulrich, Deák, István, Nagy, Eszter, Mohl, Adrienn, Schlammadinger, Ágota, Boda, Zoltán, Masszi, Tamás, Sadler, J. Evan, Bodó, Imre
Publicado em 2010

Rac, PAK and p38 regulate cell contact-dependent nuclear translocation of myocardin-related transcription factor

Por Sebe, Attila, Masszi, András, Zulys, Matthew, Yeung, Tony, Speight, Pam, Rotstein, Ori. D., Nakano, Hiroyasu, Mucsi, István, Szászi, Katalin, Kapus, András
Publicado no FEBS Lett (2007)

Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton

Por Ly, Donald L., Waheed, Faiza, Lodyga, Monika, Speight, Pam, Masszi, András, Nakano, Hiroyasu, Hersom, Maria, Pedersen, Stine F., Szászi, Katalin, Kapus, András
Publicado em 2013

Characterization and function of histamine receptors in human bone marrow stromal cells

Por Nemeth, Krisztian, Wilson, Todd, Rada, Balazs, Parmelee, Alissa, Mayer, Balazs, Buzas, Edit, Falus, Andras, Key, Sharon, Masszi, Tamas, Karpati, Sarolta, Mezey, Eva
Publicado em 2012

Reduced Estradiol-Induced Vasodilation and Poly-(ADP-Ribose) Polymerase (PARP) Activity in the Aortas of Rats with Experimental Polycystic Ovary Syndrome (PCOS)

Por Masszi, Gabriella, Horvath, Eszter Maria, Tarszabo, Robert, Benko, Rita, Novak, Agnes, Buday, Anna, Tokes, Anna-Maria, Nadasy, Gyorgy L., Hamar, Peter, Benyó, Zoltán, Varbiro, Szabolcs
Publicado em 2013

Cell Contact–dependent Regulation of Epithelial–Myofibroblast Transition via the Rho-Rho Kinase-Phospho-Myosin Pathway

Por Fan, Lingzhi, Sebe, Attila, Péterfi, Zalán, Masszi, András, Thirone, Ana C.P., Rotstein, Ori D., Nakano, Hiroyasu, McCulloch, Christopher A., Szászi, Katalin, Mucsi, István, Kapus, András
Publicado em 2007

Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study: Efficacy and Tolerability of 140 Milli...

Por Saglio, Giuseppe, Hochhaus, Andreas, Goh, Yeow Tee, Masszi, Tamas, Pasquini, Ricardo, Maloisel, Frederic, Erben, Philipp, Cortes, Jorge, Paquette, Ronald, Bradley-Garelik, M. Brigid, Zhu, Chao, Dombret, Herve
Publicado no Cancer (2010)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Por Andrikovics, Hajnalka, Krahling, Tunde, Balassa, Katalin, Halm, Gabriella, Bors, Andras, Koszarska, Magdalena, Batai, Arpad, Dolgos, Janos, Csomor, Judit, Egyed, Miklos, Sipos, Andrea, Remenyi, Peter, Tordai, Attila, Masszi, Tamas
Publicado em 2014

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE...

Por P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer
Publicado em 2022-04-01

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia

Por Nahajevszky, Sarolta, Andrikovics, Hajnalka, Batai, Arpad, Adam, Emma, Bors, Andras, Csomor, Judit, Gopcsa, Laszlo, Koszarska, Magdalena, Kozma, Andras, Lovas, Nora, Lueff, Sandor, Matrai, Zoltan, Meggyesi, Nora, Sinko, Janos, Sipos, Andrea, Varkonyi, Andrea, Fekete, Sandor, Tordai, Attila, Masszi, Tamas
Publicado em 2011

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Por Vannucchi, Alessandro M., Kiladjian, Jean Jacques, Griesshammer, Martin, Masszi, Tamas, Durrant, Simon, Passamonti, Francesco, Harrison, Claire N., Pane, Fabrizio, Zachee, Pierre, Mesa, Ruben, He, Shui, Jones, Mark M., Garrett, William, Li, Jingjin, Pirron, Ulrich, Habr, Dany, Verstovsek, Srdan
Publicado no N Engl J Med (2015)

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

Por O'Connor, Owen A., Horwitz, Steven, Masszi, Tamás, Van Hoof, Achiel, Brown, Peter, Doorduijn, Jeannette, Hess, Georg, Jurczak, Wojciech, Knoblauch, Poul, Chawla, Shanta, Bhat, Gajanan, Choi, Mi Rim, Walewski, Jan, Savage, Kerry, Foss, Francine, Allen, Lee F., Shustov, Andrei
Publicado no J Clin Oncol (2015)

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up

Por Ludwig, Heinz, Greil, Richard, Masszi, Tamas, Spicka, Ivan, Shpilberg, Ofer, Hajek, Roman, Dmoszynska, Anna, Paiva, Bruno, Vidriales, María‐Belén, Esteves, Graca, Stoppa, Anne Marie, Robinson, Don, Chaturvedi, Shalini, Ataman, Ozlem, Enny, Christopher, Feng, Huaibao, van de Velde, Helgi, Viterbo, Luisa
Publicado no Br J Haematol (2015)

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Siltuximab (Anti-IL-6 mAb) and Bortezomib versus Bortezomib Alone in Patients with Relapsed or Refractory Multiple...

Por Orlowski, Robert Z., Gercheva, Liana, Williams, Cathy, Sutherland, Heather, Robak, Tadeusz, Masszi, Tamás, Goranova-Marinova, Vesselina, Dimopoulos, Meletios A., Cavenagh, James D., Špička, Ivan, Maiolino, Angelo, Suvorov, Alexander, Bladé, Joan, Samoylova, Olga, Puchalski, Thomas A., Reddy, Manjula, Bandekar, Rajesh, van de Velde, Helgi, Xie, Hong, Rossi, Jean-François
Publicado no Am J Hematol (2015)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Por Gambacorti-Passerini, Carlo, Brümmendorf, Tim H, Kim, Dong-Wook, Turkina, Anna G, Masszi, Tamas, Assouline, Sarit, Durrant, Simon, Kantarjian, Hagop M, Khoury, H Jean, Zaritskey, Andrey, Shen, Zhi-Xiang, Jin, Jie, Vellenga, Edo, Pasquini, Ricardo, Mathews, Vikram, Cervantes, Francisco, Besson, Nadine, Turnbull, Kathleen, Leip, Eric, Kelly, Virginia, Cortes, Jorge E
Publicado em 2014